These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 33574087

  • 1. Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.
    Kurebayashi Y, Olkowski CP, Lane KC, Vasalatiy OV, Xu BC, Okada R, Furusawa A, Choyke PL, Kobayashi H, Sato N.
    Cancer Res; 2021 Jun 01; 81(11):3092-3104. PubMed ID: 33574087
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
    Chen L, Zhou S, Qin J, Hu H, Ma H, Liu B, Wang X, Ma J, Ye S, Zhong C, Zhou G, Liang C.
    Mol Cancer; 2013 Dec 05; 12(1):153. PubMed ID: 24304581
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
    Sanseviero E, O'Brien EM, Karras JR, Shabaneh TB, Aksoy BA, Xu W, Zheng C, Yin X, Xu X, Karakousis GC, Amaravadi RK, Nam B, Turk MJ, Hammerbacher J, Rubinstein MP, Schuchter LM, Mitchell TC, Liu Q, Stone EL.
    Cancer Immunol Res; 2019 Aug 05; 7(8):1371-1380. PubMed ID: 31239316
    [Abstract] [Full Text] [Related]

  • 7. Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites.
    Chaput N, Darrasse-Jèze G, Bergot AS, Cordier C, Ngo-Abdalla S, Klatzmann D, Azogui O.
    J Immunol; 2007 Oct 15; 179(8):4969-78. PubMed ID: 17911581
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer.
    Aida K, Miyakawa R, Suzuki K, Narumi K, Udagawa T, Yamamoto Y, Chikaraishi T, Yoshida T, Aoki K.
    Cancer Sci; 2014 Feb 15; 105(2):159-67. PubMed ID: 24289533
    [Abstract] [Full Text] [Related]

  • 11. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
    Jung K, Kim JA, Kim YJ, Lee HW, Kim CH, Haam S, Kim YS.
    Cancer Immunol Res; 2020 Jan 15; 8(1):46-56. PubMed ID: 31554638
    [Abstract] [Full Text] [Related]

  • 12. Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
    Campbell JR, McDonald BR, Mesko PB, Siemers NO, Singh PB, Selby M, Sproul TW, Korman AJ, Vlach LM, Houser J, Sambanthamoorthy S, Lu K, Hatcher SV, Lohre J, Jain R, Lan RY.
    Cancer Res; 2021 Jun 01; 81(11):2983-2994. PubMed ID: 33757978
    [Abstract] [Full Text] [Related]

  • 13. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L, Botling J, He F, Pelicano C, Zhou C, He C, Palano G, Mezheyeuski A, Micke P, Ravetch JV, Karlsson MCI, Sarhan D.
    Cancer Res; 2021 Feb 15; 81(4):956-967. PubMed ID: 33293426
    [Abstract] [Full Text] [Related]

  • 14. Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease.
    Gu T, Kilinc MO, Egilmez NK.
    Cancer Immunol Immunother; 2008 Jul 15; 57(7):997-1005. PubMed ID: 18049819
    [Abstract] [Full Text] [Related]

  • 15. Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy.
    Sato K, Sato N, Xu B, Nakamura Y, Nagaya T, Choyke PL, Hasegawa Y, Kobayashi H.
    Sci Transl Med; 2016 Aug 17; 8(352):352ra110. PubMed ID: 27535621
    [Abstract] [Full Text] [Related]

  • 16. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.
    Voo KS, Bover L, Harline ML, Weng J, Sugimoto N, Liu YJ.
    J Immunol; 2014 Jul 15; 193(2):627-34. PubMed ID: 24928999
    [Abstract] [Full Text] [Related]

  • 17. Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity.
    Onda M, Kobayashi K, Pastan I.
    Proc Natl Acad Sci U S A; 2019 Mar 05; 116(10):4575-4582. PubMed ID: 30760587
    [Abstract] [Full Text] [Related]

  • 18. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C, Pandit H, Nagy BA, Stellas D, Jensen SM, Bear J, Cam M, Valentin A, Fox BA, Felber BK, Pavlakis GN.
    J Immunother Cancer; 2020 May 05; 8(1):. PubMed ID: 32461349
    [Abstract] [Full Text] [Related]

  • 19. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.
    Exp Hematol; 2007 Mar 05; 35(3):416-25. PubMed ID: 17309822
    [Abstract] [Full Text] [Related]

  • 20. Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.
    Teng MW, Swann JB, von Scheidt B, Sharkey J, Zerafa N, McLaughlin N, Yamaguchi T, Sakaguchi S, Darcy PK, Smyth MJ.
    Cancer Res; 2010 Apr 01; 70(7):2665-74. PubMed ID: 20332236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.